Back
Royalty Pharma PLC Vs. Amphastar Pharmaceuticals Industry Stock Comparison
Sell
31
RPRX
Royalty Pharma PLC
Last Price:
27.26
Seasonality Move:
-2.02%
Buy
69
AMPH
Amphastar Pharmaceuticals
Last Price:
43.50
Seasonality Move:
7.25%
Sell
31
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $27.27. The Score for RPRX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Amphastar Pharmaceuticals (AMPH)
is a Buy
Is Amphastar Pharmaceuticals a Buy, Sell or Hold?
- The current Amphastar Pharmaceuticals [AMPH] share price is $43.48. The Score for AMPH is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- AMPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $27.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing selling pressure, which indicates risk of future bearish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals's stock price today?
-
The Amphastar Pharmaceuticals share price today is $43.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
RPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 36.31 | Sell |
Chaikin Money Flow: | -1694297 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.71 - 28.35) | Sell |
Bollinger Bands (100): | (27.98 - 30.06) | Sell |
AMPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 58.34 | Buy |
Chaikin Money Flow: | 272748 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.46 - 42.7) | Buy |
Bollinger Bands (100): | (41.4 - 55.64) | Sell |
RPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.98 | Sell |
20-day SMA: | 28.07 | Sell |
50-day SMA: | 28.92 | Sell |
200-day SMA: | 28.57 | Sell |
8-day EMA: | 27.92 | Sell |
20-day EMA: | 28.15 | Sell |
50-day EMA: | 28.59 | Sell |
200-day EMA: | 29.61 | Sell |
AMPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.4 | Buy |
20-day SMA: | 41.96 | Buy |
50-day SMA: | 42.19 | Buy |
200-day SMA: | 50.25 | Sell |
8-day EMA: | 42.54 | Buy |
20-day EMA: | 42.18 | Buy |
50-day EMA: | 43.5 | Sell |
200-day EMA: | 47.41 | Sell |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.20 per share, and an increase next year of $0.38 per share.
Amphastar Pharmaceuticals Earnings Growth & AMPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.09 per share, an increase this year of $0.35 per share, and an increase next year of $0.39 per share.
Royalty Pharma PLC Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amphastar Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |